Neurimmune AG

Swiss Biotech Association

Member

Neurimmune is a biopharmaceutical company translating human immune memory into transformative antibody therapeutics. Neurimmune discovered aducanumab, a human monoclonal antibody targeting amyloid beta for the treatment of Alzheimer's disease, and licensed it to Biogen.

Location

Wagistrasse 18, 8952 Schlieren, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2006
Number of employees in Switzerland

50-149

Key business

Core competencies

You may also be interested in

InkVivo Technologies AG

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricated novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).
Lugano

Member

GxpManager

GxpManager is a Software editor proposing a SaaS platform with Low Code No Code applications to digitize, manage and process critical data within regulatory requirements in the life sciences sector.
69009 Lyon

Member

Provectis Healthcare AG

Provectis Healthcare AG is a global healthcare company based in Basel and the commercial partner of choice to the innovative biopharma. We advance the innovation through launch, commercialization and brand building in Europe, Middle East and Asia.
4051 Basel

Member